Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,755.20
(
-1.56%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
107.83
(
1.17%
)
Bitcoin
71,138.88
(
-0.14%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: alertmeipp post# 81561

Tuesday, 07/28/2009 4:24:27 PM

Tuesday, July 28, 2009 4:24:27 PM

Post# of 257257
TEVA BIIB ELN:

But if u look at just the last couple quarters... Tysabri is superior :)

Actually, it wasn’t. Referring to the table in #msg-39941769: in the past two quarters, the cumulative growth of US Tysabri sales was 8.7% while the cumulative growth of US Copaxone sales was 14.1%.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now